Cancer News and Research

Latest Cancer News and Research

Experts at Ninth International Symposium discuss health effects and safety of S-equol

The latest research into the health effects and safety of a soy-based compound called S-equol was described in talks and presentations by experts at a special session on Tuesday, Oct. 19 during the Ninth International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment, held Oct. 16 to 19 in Washington, D.C.

20 Oct 2010

Mirna announces USPTO allows claims to therapeutic application of let-7 miRNA

Mirna Therapeutics, Inc. announced today that the USPTO has allowed claims related to the therapeutic application of let-7 in the regulation of oncogenes. The claims derive from a patent application that was submitted by Yale University and exclusively licensed to Mirna related to the pioneering work of Dr. Frank Slack, Professor of Molecular, Cellular & Developmental Biology at Yale University in New Haven, CT.

20 Oct 2010

MD Anderson treats lung cancer with pencil beam scanning proton therapy

Pencil beam scanning technology, an even more advanced and targeted form of radiation treatment known as proton therapy, is now being used to treat patients with lung cancer at The University of Texas MD Anderson Cancer Center.

20 Oct 2010

Salix acquires rights to colon cancer screening agent from Photocure

Salix Pharmaceuticals, Ltd. today announced that the Company has acquired rights to Lumacan™ from Photocure, a Norwegian specialty pharmaceutical company. Lumacan is a novel agent designed to assist in the detection of precancerous and cancerous lesions in the colon.

20 Oct 2010

SHIP and PTEN enzymes act cooperatively to suppress B cell lymphoma: Study

Lymphoma is a cancer of the immune system. White blood cells divide again and again, spreading abnormally throughout the body. Lymphomas can arise from two types of white blood cells, T cells or B cells, which divide uncontrollably when the molecular mechanisms that keep them in check go awry.

20 Oct 2010

New disease pathways involving more than one cell type lead to Type 1 Gaucher disease: Study

Researchers at Yale School of Medicine have found that new disease pathways involving more than one cell type leads to Type 1 Gaucher disease, a rare genetic disorder in which fatty substances called glycosphingolipids accumulate in cells, resulting in liver/spleen enlargement, osteoporosis, bone pain, and increased risk of cancer and Parkinson's disease.

20 Oct 2010

Inguinal lymph node dissection with spinal anesthesia improves prognosis in patients with malignant melanoma

A study presented at this year's American Society of Anesthesiologists Annual Meeting offers evidence that patients with malignant melanoma who undergo inguinal lymph node dissection with spinal anesthesia (a regional anesthetic) have a better prognosis than patients who undergo the same surgery with general anesthesia.

20 Oct 2010

MabCure announces agreement with Europe's medical centers to explore diagnostic test for ovarian cancer

Biotechnology company MabCure, Inc. today announced that it has signed a collaboration agreement with Catholic University, K.U. Leuven and University Hospital, UZ Leuven, Belgium, together comprising one of the largest and most reputable medical centers in Europe.

20 Oct 2010

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

20/20 GeneSystems, Inc. announced today at the AdvaMed MedTech Conference in Washington, D.C. that the company has been awarded nearly $3 million in grants from the National Cancer Institute's (NCI) Small Business Innovative Research (SBIR) Program to develop tests to help oncologists predict the effectiveness of targeted cancer therapies.

20 Oct 2010

BCAN holds regional Bladder Cancer Patient Forum at New York Academy of Medicine

Bladder cancer is the fifth most commonly diagnosed cancer in the United States, yet most people know nothing about it. To help enhance the public's understanding of the risks and signs of bladder cancer and the importance of early detection and treatment options, the Bladder Cancer Advocacy Network (BCAN) will hold its regional Bladder Cancer Patient Forum "Understanding Bladder Cancer" on Saturday, October 23, 2010, in New York City at the New York Academy of Medicine.

20 Oct 2010

Japanese study finds proton beam therapy safe and effective for Stage I inoperable NSCLC

Proton beam therapy is safe and effective and may be superior to other conventional treatments for Stage I inoperable non-small cell lung cancer (NSCLC) patients, according to a study in the October issue of the International Journal of Radiation Oncology•Biology•Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

20 Oct 2010

LCRF receives 2.1 million dollar donation

The largest donation in the Lung Cancer Research Foundation's history was announced in New York today by LCRF founder Laurie C. Carson.

20 Oct 2010

OncoGenex announces pricing of public offering

OncoGenex Pharmaceuticals, Inc. today announced that it has priced a public offering of 3,174,602 units, with each unit consisting of one share of the Company's common stock and one-half (1/2) of one warrant, at a purchase price of $15.75 per unit for an aggreate offering amount of $50 million.

20 Oct 2010

Adamis acquires prostrate drug candidates from Colby Pharmaceuticals

Adamis Pharmaceuticals Corporation today announced the completion of the acquisition from Colby Pharmaceuticals of the remaining exclusive license agreements relating to two drug product candidates for the treatment of prostate cancer (PCa).

20 Oct 2010

MannKind begins MKC1106-MT Phase 2 trial for advanced melanoma

MannKind Corporation today announced the first patient has been dosed in a phase 2 clinical trial of the novel, investigational cancer vaccine MKC1106-MT. As a part of MannKind's cancer immunotherapy program, this phase 2 study will evaluate the safety, tolerability, immune response and clinical response of MKC1106-MT in patients with advanced melanoma.

20 Oct 2010

Long term exposure to air pollution increases risk of severe COPD

Long term exposure to low-level air pollution may increase the risk of severe chronic obstructive pulmonary disease (COPD), according to researcher s in Denmark. While acute exposure of several days to high level air pollution was known to be a risk factor for exacerbation in pre-existing COPD, until now there had been no studies linking long-term air pollution exposure to the development or progression of the disease.

20 Oct 2010

454 Life Sciences enters co-promotional agreement with Fluidigm

454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.

20 Oct 2010

CIED implantation with AIGISRx Antibacterial Envelope reduces overall infection rate

Patients undergoing CIED (Cardiac Implantable Electronic Device) implantation with TYRX, Inc.'s FDA-cleared AIGISRx Antibacterial Envelope enjoyed a 99.5% rate of successful implantation with an overall infection rate of 0.48% in the first 1.9 months following the procedure, as reported in newly published results of TYRX's COMMAND Clinical Study.

20 Oct 2010

Researchers to study effectiveness of gamma-tocotrienol on prostate cancer cells

Survival rates of the world's most common cancer might soon be increased with a new vitamin E treatment which could significantly reduce tumour regrowth. Queensland University of Technology (QUT) prostate cancer researchers are leading the fight against a disease which kills 3000 Australian men a year.

20 Oct 2010

Study finds adipose dysfunction linked to steatosis, necroinflammation in G1 CHC patients

Researchers at the University of Palermo in Italy provide the evidence that a higher visceral adiposity index score-a new index of adipose dysfunction-has a direct correlation with viral load and is independently associated with both steatosis and necroinflammatory activity in patients with genotype 1 chronic hepatitis C (G1 CHC).

20 Oct 2010

Cancer News and Research

Latest Cancer News and Research

Experts at Ninth International Symposium discuss health effects and safety of S-equol

Mirna announces USPTO allows claims to therapeutic application of let-7 miRNA

MD Anderson treats lung cancer with pencil beam scanning proton therapy

Salix acquires rights to colon cancer screening agent from Photocure

SHIP and PTEN enzymes act cooperatively to suppress B cell lymphoma: Study

New disease pathways involving more than one cell type lead to Type 1 Gaucher disease: Study

Inguinal lymph node dissection with spinal anesthesia improves prognosis in patients with malignant melanoma

MabCure announces agreement with Europe's medical centers to explore diagnostic test for ovarian cancer

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

BCAN holds regional Bladder Cancer Patient Forum at New York Academy of Medicine

Japanese study finds proton beam therapy safe and effective for Stage I inoperable NSCLC

LCRF receives 2.1 million dollar donation

OncoGenex announces pricing of public offering

Adamis acquires prostrate drug candidates from Colby Pharmaceuticals

MannKind begins MKC1106-MT Phase 2 trial for advanced melanoma

Long term exposure to air pollution increases risk of severe COPD

454 Life Sciences enters co-promotional agreement with Fluidigm

CIED implantation with AIGISRx Antibacterial Envelope reduces overall infection rate

Researchers to study effectiveness of gamma-tocotrienol on prostate cancer cells

Study finds adipose dysfunction linked to steatosis, necroinflammation in G1 CHC patients

Industry Focus eBook - Immunology (3rd edition) eBook

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Immunology (3rd edition) eBook

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Newsletters you may be interested in